Neuralink VOICE speech-restoration trial

Mapped to your portfolio

Overview

Description Neuralink’s VOICE trial is testing whether the N1 brain implant can restore communication through text and synthetic speech. Overview Neuralink’s N1 implant translated neural activity into audible words for a patient with amyotrophic lateral sclerosis. Kenneth Shock, the third patient in the trial described…

Possible scenarios

40%Developer Adoption Builds+0.1%
25%Platform Partnership Emerges+0.2%
20%Technical Limits Surface0.0%

For information only. Not investment advice.

Stories in this saga

2 stories, 3 sources

Sep 19, 2026
Neuralink N1 Implant Synthesizes Speech for 3rd Patient in VOICE Trial
Oct 9, 2026

Neuralink VOICE speech-restoration trial

Mapped to your portfolio

Overview

Possible scenarios

Stories in this saga

Neuralink N1 Implant Synthesizes Speech for 3rd Patient in VOICE Trial

Sabi Raises $50M for Wearable Cap to Prompt AI by Thinking

Portfolio

Possible scenarios

Mapped to your portfolio

Mapped to your portfolio

Overview

Possible scenarios

Keeping an eye on this saga?

Stories in this saga

Neuralink N1 Implant Synthesizes Speech for 3rd Patient in VOICE Trial

Sabi Raises $50M for Wearable Cap to Prompt AI by Thinking

Portfolio

Possible scenarios

Mapped to your portfolio